These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 14707441
1. Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis. Jung M, Christgau S, Lukoschek M, Henriksen D, Richter W. Pathobiology; 2004; 71(2):70-6. PubMed ID: 14707441 [Abstract] [Full Text] [Related]
2. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, Delmas PD. Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919 [Abstract] [Full Text] [Related]
3. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Charni N, Juillet F, Garnero P. Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703 [Abstract] [Full Text] [Related]
4. Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations. Rousseau JC, Chevrel G, Schott AM, Garnero P. Bone; 2010 Apr; 46(4):897-900. PubMed ID: 20005316 [Abstract] [Full Text] [Related]
5. Increased urinary type II collagen C-telopeptide levels in Tunisian patients with knee osteoarthritis. Kalai E, Bahlous A, Charni N, Bouzid K, Sahli H, Chelly M, Meddeb M, Zouari B, Abdelmoula J, Sellami S. Clin Lab; 2012 Apr; 58(3-4):209-15. PubMed ID: 22582493 [Abstract] [Full Text] [Related]
6. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. Garnero P, Gineyts E, Christgau S, Finck B, Delmas PD. Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593 [Abstract] [Full Text] [Related]
7. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. Kong SY, Stabler TV, Criscione LG, Elliott AL, Jordan JM, Kraus VB. Arthritis Rheum; 2006 Aug; 54(8):2496-504. PubMed ID: 16868970 [Abstract] [Full Text] [Related]
8. Does hand osteoarthritis predict future hip or knee osteoarthritis? Dahaghin S, Bierma-Zeinstra SM, Reijman M, Pols HA, Hazes JM, Koes BW. Arthritis Rheum; 2005 Nov; 52(11):3520-7. PubMed ID: 16255023 [Abstract] [Full Text] [Related]
9. Association between spine disc degeneration and type II collagen degradation in postmenopausal women: the OFELY study. Garnero P, Sornay-Rendu E, Arlot M, Christiansen C, Delmas PD. Arthritis Rheum; 2004 Oct; 50(10):3137-44. PubMed ID: 15476251 [Abstract] [Full Text] [Related]
10. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers. Cibere J, Thorne A, Kopec JA, Singer J, Canvin J, Robinson DB, Pope J, Hong P, Grant E, Lobanok T, Ionescu M, Poole AR, Esdaile JM. J Rheumatol; 2005 May; 32(5):896-902. PubMed ID: 15868627 [Abstract] [Full Text] [Related]
11. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E. Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852 [Abstract] [Full Text] [Related]
12. Relationship between radiological knee osteoarthritis and biochemical markers of cartilage and bone degradation (urine CTX-II and NTX-I): the Matsudai Knee Osteoarthritis Survey. Tanishi N, Yamagiwa H, Hayami T, Mera H, Koga Y, Omori G, Endo N. J Bone Miner Metab; 2009 Jun; 27(5):605-12. PubMed ID: 19381754 [Abstract] [Full Text] [Related]
13. Correlation Analysis of C-terminal telopeptide of collagen type II and Interleukin-1β for Early Diagnosis of Knee Osteoarthritis. Liu CX, Gao G, Qin XQ, Deng CQ, Shen XJ. Orthop Surg; 2020 Feb; 12(1):286-294. PubMed ID: 31840428 [Abstract] [Full Text] [Related]
14. Large scale meta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein and matrix metalloprotease degraded type II collagen and their role in prevalence, incidence and progression of osteoarthritis. Valdes AM, Meulenbelt I, Chassaing E, Arden NK, Bierma-Zeinstra S, Hart D, Hofman A, Karsdal M, Kloppenburg M, Kroon HM, Slagboom EP, Spector TD, Uitterlinden AG, van Meurs JB, Bay-Jensen AC. Osteoarthritis Cartilage; 2014 May; 22(5):683-9. PubMed ID: 24576742 [Abstract] [Full Text] [Related]
15. Usefulness of urinary CTX-II and NTX-I in evaluating radiological knee osteoarthritis : the Matsudai knee osteoarthritis survey. Tanishi N, Yamagiwa H, Hayami T, Mera H, Koga Y, Omori G, Endo N. J Orthop Sci; 2014 May; 19(3):429-36. PubMed ID: 24504986 [Abstract] [Full Text] [Related]
16. Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis. Lohmander LS, Yoshihara Y, Roos H, Kobayashi T, Yamada H, Shinmei M. J Rheumatol; 1996 Oct; 23(10):1765-9. PubMed ID: 8895155 [Abstract] [Full Text] [Related]
18. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, Rosenquist C, Qvist P. Bone; 2001 Sep; 29(3):209-15. PubMed ID: 11557363 [Abstract] [Full Text] [Related]
19. Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training. Petersen SG, Saxne T, Heinegard D, Hansen M, Holm L, Koskinen S, Stordal C, Christensen H, Aagaard P, Kjaer M. Osteoarthritis Cartilage; 2010 Jan; 18(1):34-40. PubMed ID: 19679221 [Abstract] [Full Text] [Related]
20. Urinary collagen type II C-telopeptide fragments are sensitive markers of matrix metalloproteinase-dependent cartilage degradation in rat adjuvant-induced arthritis. De Ceuninck F, Sabatini M, Renoux V, de Nanteuil G, Pastoureau P. J Rheumatol; 2003 Jul; 30(7):1561-4. PubMed ID: 12858459 [Abstract] [Full Text] [Related] Page: [Next] [New Search]